Effect of pregabalin premedication on emergence agitation in children after sevoflurane anesthesia: a randomized controlled study.
Not Applicable
Recruiting
- Conditions
- AnaesthesiaPaediatricsemergence agitation in children after sevoflurane anesthesia
- Registration Number
- PACTR201705002301312
- Lead Sponsor
- tanta university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
aged 4-10 years, ASA I-II, scheduled for adenotonsillectomy under sevoflurane anaesthesia
Exclusion Criteria
include mental or developmental retardation, allergy to the study medications hyperactivity disorders,renal or liver diseases, or use of psychiatric medications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pregabalin's effect on emergence agitation in pediatric sevoflurane anesthesia?
How does pregabalin premedication compare to midazolam in reducing emergence agitation in children undergoing sevoflurane anesthesia?
Are there specific biomarkers that predict children's response to pregabalin premedication for emergence agitation prevention?
What are the potential adverse events associated with pregabalin premedication in pediatric anesthesia and how can they be managed?
What combination therapies or alternative drugs are being explored alongside pregabalin to address emergence agitation in children post-sevoflurane anesthesia?